Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...
An FDA advisory panel recommended use of an experimental Replimune treatment for advanced melanoma that the agency has rejected twice ...
Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their ...
In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to full ...
Federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June.
UCSD researchers have spent years building trust in communities of unhoused people who use drugs in San Diego and across the border in Tijuana. Since spring, some 10% of their research participants ...
The ADA is no longer what we’d call a profile in courage,” write Adam Marcus and Ivan Oransky of Retraction Watch.
The appropriate counter to Covid revisionism is careful, rigorous, and honest assessment of the U.S. response.” ...
Too often, regulatory tools authorized to speed patient access to breakthrough treatments are being used in ways that even prevent approval,” writes Kat Bryant Knudson.
A group of outside experts convened by the Food and Drug Administration on Thursday voted in favor of Replimune’s experimental treatment for advanced melanoma. In a 10-3 vote, t ...
Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results